Volume 133, Issue 2, Pages (August 2007)

Slides:



Advertisements
Similar presentations
YouTube® and inflammatory bowel disease
Advertisements

C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies  Welmoed K. Van Deen, Andrea E.
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis  Jeffrey Hyams, Lakshmi Damaraju, Marion Blank,
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Reply Gastroenterology
Volume 136, Issue 2, Pages (February 2009)
The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to- Moderately Active Ulcerative Colitis  Ajit Sood, Vandana Midha, Govind K.
Volume 147, Issue 4, Pages e7 (October 2014)
Volume 133, Issue 2, Pages (August 2007)
Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab  Dan Turner, Anne M. Griffiths,
The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children  Jeffrey Hyams, James Markowitz, Trudy Lerer, Anne Griffiths, David Mack,
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Clinical Challenges and Images in GI
Volume 137, Issue 2, Pages (August 2009)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 135, Issue 5, Pages (November 2008)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 150, Issue 4, Pages (April 2016)
Multiple Masses in the Colon of a Patient With Ulcerative Colitis
Volume 135, Issue 6, Pages (December 2008)
Reply Gastroenterology
Volume 152, Issue 1, Pages (January 2017)
Atopic Characteristics of Adult Patients With Eosinophilic Esophagitis
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis  John Gubatan, Shuji Mitsuhashi, Talia Zenlea,
Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis  Jing Hieng Ngu, Richard Blair Gearry, Andrew.
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Efficient Early Drug Development for Ulcerative Colitis
Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A. Moum, Morten H. Vatn 
Basavaraj Kerur, Jason T. Machan, Jason M. Shapiro, Carolina S
Volume 133, Issue 6, Pages (December 2007)
Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases  Michael D.
Time Trends of Ulcer Mortality in Europe
Volume 136, Issue 5, Pages (May 2009)
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 150, Issue 5, Pages (May 2016)
The Reply The American Journal of Medicine
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome  Claudia I. Reinders, Max Herulf, Tryggve Ljung,
Volume 145, Issue 5, Pages (November 2013)
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 140, Issue 6, Pages e2 (May 2011)
Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies  Hai Yun.
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
The Dawning of a New Editorial Board for Gastroenterology
John S. Kane, Olorunda Rotimi, Simon M
Volume 151, Issue 4, Pages (October 2016)
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Advances in Minimally Invasive Surgery
Volume 138, Issue 4, Pages e2 (April 2010)
Volume 132, Issue 3, Pages (March 2007)
Volume 131, Issue 2, Pages (August 2006)
Volume 148, Issue 4, Pages (April 2015)
Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry  Jolanda M. White, Siobhán.
David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford 
Volume 155, Issue 6, Pages (December 2018)
Current Practice in the Diagnosis of Bile Acid Diarrhea
Volume 139, Issue 6, Pages e1 (December 2010)
Reply Gastroenterology
David S. Fefferman, Richard J. Farrell 
Volume 134, Issue 3, Pages (March 2008)
Issue Highlights Clinical Gastroenterology and Hepatology
Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis  Francesc Casellas, Maria Antolı́n, Encarnación.
Assessing activity of pediatric Crohn's disease: Which index to use?
Presentation transcript:

Volume 133, Issue 2, Pages 423-432 (August 2007) Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study  Dan Turner, Anthony R. Otley, David Mack, Jeffrey Hyams, J. de Bruijne, Krista Uusoue, Thomas D. Walters, Mary Zachos, Petar Mamula, Dorcas E. Beaton, A. Hillary Steinhart, Anne M. Griffiths  Gastroenterology  Volume 133, Issue 2, Pages 423-432 (August 2007) DOI: 10.1053/j.gastro.2007.05.029 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Study design and outline of the PUCAI development. Footnote: Construct validity is a minitheory to explain whether a measure acts the way it is expected based on the concept that it represents. Concurrent validity reflects the relationship of the index to another instrument measuring a similar attribute and convergent validity of the relationship with another established index. Extreme group validity reflects whether the measure differentiates extreme sides of the disease spectrum. Interobserver reliability reflects whether an index is reproducible between different raters at the same time and test-retest reliability whether a score is reproducible at different times, when the patient remains stable. Responsiveness reflects the ability of an instrument to detect accurately the change in disease activity over time, when it occurs. IBD, inflammatory bowel disease; UC, ulcerative colitis. Gastroenterology 2007 133, 423-432DOI: (10.1053/j.gastro.2007.05.029) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Cut-off and change scores of the PUCAI. (A) PUCAI score distribution of the combined weighting and validation cohort (n = 205), stratified by the Physician’s Global Assessment of disease activity. The median PUCAI scores were significantly different across the 4 groups (Kruskal–Wallis test = 1783, P < .001). ROC, sensitivity, and specificity were calculated for “none” vs “mild,” “mild” vs “moderate,” and “moderate” vs “severe.” (B) ΔPUCAI (the difference in the score between baseline and follow-up visits) stratified by physician global assessment of change (on a 7-point Likert scale of change). The median ΔPUCAI was significantly different across the 4 groups (Kruskal–Wallis test = 42.63, P < .001). AUC, area under the curve; ROC, receiver operator characteristic. Gastroenterology 2007 133, 423-432DOI: (10.1053/j.gastro.2007.05.029) Copyright © 2007 AGA Institute Terms and Conditions